Ignite Creation Date:
2025-12-25 @ 2:19 AM
Ignite Modification Date:
2025-12-27 @ 11:01 PM
Study NCT ID:
NCT00880334
Status:
COMPLETED
Last Update Posted:
2018-09-18
First Post:
2009-04-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2013-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-05
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-10
First Submit QC Date:
None
Study First Post Date:
2009-04-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-04-15
Results First Submit QC Date:
None
Results First Post Date:
2014-06-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-20
Last Update Post Date:
2018-09-18
Last Update Post Date Type:
ACTUAL